+41 91 682 20 40
info@elixi-int.com
Reserved Area
Login
Register
Request Document
Send Document
Home
About Us
Services
Quality
News
Case Studies
Contact
Online Store
Let's talk
info@yourwebsite.com
+1 (555) 123-4567
Search
refractory mantle cell lymphoma (MCL).
11 February 2020
FDA Grants Priority Review for Kite’s KTE-X19 Biologics License Application (BLA) in Relapsed or Refractory Mantle Cell Lymphoma
by Elixi